Explore our portfolio of surgical clinical trials aimed at optimizing treatment protocols, improving recovery, and reducing complications across gynecologic cancers.
This resource is intended for patients, healthcare professionals, and researchers seeking up-to-date information on ongoing and completed surgical studies within the NSGO-CTU network.
For detailed eligibility criteria, site information, or additional inquiries, please contact the assigned Project Manager.
ENGOT-OV20/DESKTOP III
A randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer.
ENGOT-OV33/TRUST
Trial of radical upfront surgery in advanced ovarian cancer: amendment for Germany with extended part for fragility and long term quality of life.
ENGOT-OV34/AGO-OVAR 2.29
Atezolizumab in combination with Bevacizumab and Chemotherapy versus Bevacizumab and Chemotherapy in recurrent ovarian cancer – a randomized Phase III trial.
ENGOT-OV52/OVHIPEC-2
Phase III randomized clinical trial for stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy.